AmSurg (AMSG) Reports In-Line Q3 EPS, FY Rev. Guidance Tops Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
AMSURG Reports Third-Quarter Diluted EPS of $0.69 and Adjusted Diluted EPS of $1.13
November 1, 2016 4:06 PM EDTAdjusts 2016 Financial Guidance
NASHVILLE, Tenn.--(BUSINESS WIRE)-- AMSURG Corp. (NASDAQ: AMSG) today announced financial results for the third quarter and nine months ended September 30, 2016. The Companys results for the quarter, compared with the third quarter of 2015, included:
Net revenues of $822.2 million, up 26% from $650.2 million for the third quarter of 2015; Net earnings attributable to AMSURG common shareholders of $37.7 million, a decline of 7%, and $0.69 per diluted share, a decline of 17%, primarily due to transaction costs related to AMSURGs proposed merger with Envision Healthcare and to AMSURGs... More